Globalstar, Inc Common Stock (GSAT) had the highest return in 2013 by a large-cap US stock or large-cap US stock in the Nasdaq Composite (IXIC), returning 446.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Globalstar, Inc Common Stock (GSAT) | 2013 | 446.88% |
Arrowhead Pharmaceuticals (ARWR) | 2013 | 402.31% |
Tesla (TSLA) | 2013 | 329.81% |
Netflix (NFLX) | 2013 | 286.71% |
Ionis Pharmaceuticals (IONS) | 2013 | 274.79% |
Alnylam Pharmaceuticals (ALNY) | 2013 | 239.31% |
Micron Technology (MU) | 2013 | 229.55% |
Incyte (INCY) | 2013 | 202.81% |
Genmab A-S (GMAB) | 2013 | 179.57% |
Diamondback Energy (FANG) | 2013 | 171.74% |
DexCom (DXCM) | 2013 | 154.93% |
Insmed (INSM) | 2013 | 152.23% |
Jazz Pharmaceuticals (JAZZ) | 2013 | 132.95% |
Halozyme Therapeutics (HALO) | 2013 | 115.06% |
Corcept Therapeutics (CORT) | 2013 | 111.18% |
Trip Group Ltd ADR (TCOM) | 2013 | 111.15% |
United Therapeutics (UTHR) | 2013 | 107.91% |
T-Mobile US (TMUS) | 2013 | 103.01% |
Gilead Sciences (GILD) | 2013 | 102.13% |
Cognex (CGNX) | 2013 | 102.06% |
CoStar (CSGP) | 2013 | 101.77% |
Align Technology (ALGN) | 2013 | 100% |
Facebook (META) | 2013 | 99.16% |
Illumina (ILMN) | 2013 | 97.13% |
Marvell Technology (MRVL) | 2013 | 96.98% |
Large-cap stocks are treated as having a market cap of $10B+.